News: NCI

« Previous Page

Folate May Lower Breast Cancer Risk

Friday, August 5th, 2011

A new study by investigators from Vanderbilt-Ingram Cancer Center and the Shanghai Cancer Institute indicates that women who get adequate amounts of folate in their diet have a reduced risk of developing breast cancer, although the benefit appears linked to a woman’s menopausal status. The study found that women who had not yet reached menopause […]

Lung Cancer Study Suggests Therapy Change

Friday, July 29th, 2011

A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer (NSCLC) cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Based on the differential growth rates, the study suggests that a change in the timing and dosages […]

Study Seeks Clues to Halt Metastasis’ March

Friday, July 22nd, 2011

Cancer cells grow in a seemingly haphazard fashion. They have lost the ability to connect with neighboring cells in a normal, well-ordered way. Instead, these microscopic “pirates” have acquired the ability to invade normal tissues and to wreak damage long distances through a process known as “metastasis.” E-cadherin, a protein that “glues” normal cells together, […]

Soy Not a Risk for Breast Cancer Survivors

Tuesday, April 5th, 2011

After years of confusion about the safety of soy food consumption by breast cancer survivors, a large new study found that eating soy foods did not increase the risk of cancer recurrence or death among breast cancer survivors. The study was presented at the American Association for Cancer Research (AACR) annual meeting in Orlando, Fla. […]

Cancer Gene’s Role in Outcomes Prediction

Friday, March 25th, 2011

A new study by Vanderbilt-Ingram Cancer Center investigators reveals that a gene signature may be useful in predicting outcomes for patients with rhabdomyosarcoma, a form of cancer most commonly diagnosed in children. The study, carried out by first author Jennifer Rosenbluth, Ph.D.; Jennifer Pietenpol, Ph.D., professor of Biochemistry, Cancer Biology and Otolaryngology and director of […]

Study Snuffs Out Menthol Myths

Friday, March 25th, 2011

People who smoke mentholated cigarettes are no more likely to develop lung cancer or to die from the disease than smokers of non-mentholated cigarettes, according to a new study led by Vanderbilt-Ingram Cancer Center’s William Blot, Ph.D., and colleagues at Meharry Medical College and the International Epidemiology Institute, Rockville, Md. The new smoking study was […]

Prevent Colorectal Cancer with Screenings

Friday, March 18th, 2011

What is Colon/Rectal Cancer? Colorectal cancer begins in the colon or rectum and can be referred as colon or rectal cancer depending upon where the cancer starts. Colon and rectal cancer have many commonalities, but they tend to be treated differently. In order to understand colorectal cancer, it helps to be familiar with the structure […]

Grants to Fund Research on Early Detection

Thursday, November 4th, 2010

The National Cancer Institute has awarded two Early Detection Research Network (EDRN) grants to a group of Vanderbilt-Ingram Cancer Center investigators to support early detection of lung and colon cancers. Pierre Massion, M.D., associate professor of Medicine and Cancer Biology, has been awarded $3 million over five years for the creation of the Vanderbilt Clinical […]

VICC Lands Major NCI Grant Renewal

Thursday, October 28th, 2010

Vanderbilt-Ingram Cancer Center has been awarded a five-year renewal of its Cancer Center Support Grant (CCSG) from the National Cancer Institute. Under the NCI’s Cancer Center Support Grant Program, VICC will receive more than $6.2 million per year for the next five years. The total represents a 12.7 percent increase over the previous award. The […]

New Campaign Highlights VICC’s Role As NCI Comprehensive Cancer Center

Friday, April 16th, 2010

With the launch of a new streamlined call center and the near-completion of a major expansion and renovation of its Henry-Joyce Cancer Clinic, the Vanderbilt-Ingram Cancer Center has embarked on its first advertising campaign in nine years. The campaign’s goal is to assure that more residents of Middle Tennessee are aware of the special resource they have in Vanderbilt-Ingram as a Comprehensive Cancer Center designated by the National Cancer Institute — one of only 40 in the United States and the only one in Tennessee that treats patients of all ages, with all cancer types.